Literature DB >> 30328410

Clinical and Epidemiological Characteristics of Patients with Dientamoeba fragilis Infection.

Lucía Miguel1, Fernando Salvador1, Elena Sulleiro2, Adrián Sánchez-Montalvá1, Daniel Molina-Morant1, Isabel López2, Israel Molina1.   

Abstract

Dientamoeba fragilis is an intestinal protozoan, usually considered nonpathogenic. However, in the last years, there has been an attempt to clarify its possible pathogenic role. We aim to evaluate the clinical and epidemiological characteristics of D. fragilis-infected patients. Adults with D. fragilis detection in feces who attended the Vall d'Hebron University Hospital (Barcelona, Spain) were evaluated retrospectively from April 2009 to March 2014. We classified the patients in asymptomatic, symptomatic without other causes except infection of D. fragilis, and symptomatic with another cause. Among symptomatic patients, treatment response was evaluated. One hundred eight patients were included. Sixty-three percent of the patients were immigrants, 29.6% were autochthonous, and 7.4% were travelers. Forty-nine (45.3%) patients presented symptoms, and eosinophilia was observed in 26 (24.1%) patients. Overall, 59 (54.7%) patients were asymptomatic, 15 (13.8%) presented symptoms which were attributable to other causes, and 34 (31.5%) patients presented symptoms with no other causes. In this last group, 29 patients received specific treatment and 65.5% of them presented a complete resolution of the symptoms. The group of symptomatic patients with no other cause had more proportion of women, more proportion of autochthonous people, and were older compared with the group of asymptomatic patients. Dientamoeba fragilis infection should be considered as pathogenic when other causes are ruled out.

Entities:  

Mesh:

Year:  2018        PMID: 30328410      PMCID: PMC6221219          DOI: 10.4269/ajtmh.18-0433

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Cyst formation and faecal-oral transmission of Dientamoeba fragilis--the missing link in the life cycle of an emerging pathogen.

Authors:  Varuni S Munasinghe; Nicole G F Vella; John T Ellis; Peter A Windsor; Damien Stark
Journal:  Int J Parasitol       Date:  2013-07-19       Impact factor: 3.981

2.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  [On the epidemiology of Dientamoeba fragilis Jepps and Dobell 1918. 4th communication: evidence of Dientamoeba fragilis in Enterobius eggs using isoelectric point determination].

Authors:  G Ockert; T Schmidt
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1976

4.  Incidence of Dientamoeba fragilis in faecal samples submitted for routine microbiological analysis.

Authors:  J J Windsor; A M Rafay; A K Shenoy; E H Johnson
Journal:  Br J Biomed Sci       Date:  1998-09       Impact factor: 3.829

5.  Dientamoeba fragilis colonization is not associated with gastrointestinal symptoms in children at primary care level.

Authors:  Gea A Holtman; Justin J Kranenberg; Marco H Blanker; Alewijn Ott; Yvonne Lisman-van Leeuwen; Marjolein Y Berger
Journal:  Fam Pract       Date:  2016-10-26       Impact factor: 2.267

6.  Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

Authors:  Anne Line Engsbro; C Rune Stensvold; Henrik V Nielsen; Peter Bytzer
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

Review 7.  Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis.

Authors:  Eugene H Johnson; Jeffrey J Windsor; C Graham Clark
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Description of Dientamoeba fragilis cyst and precystic forms from human samples.

Authors:  D Stark; L S Garcia; J L N Barratt; O Phillips; T Roberts; D Marriott; J Harkness; J T Ellis
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

9.  Dientamoeba fragilis--a protozoal infection which may cause severe bowel distress.

Authors:  A Norberg; C E Nord; B Evengård
Journal:  Clin Microbiol Infect       Date:  2003-01       Impact factor: 8.067

10.  Is the treatment of Enterobius vermicularis co-infection necessary to eradicate Dientamoeba fragilis infection?

Authors:  José A Boga; Susana Rojo; Jonathan Fernández; Mercedes Rodríguez; Carmen Iglesias; Pablo Martínez-Camblor; Fernando Vázquez; Azucena Rodríguez-Guardado
Journal:  Int J Infect Dis       Date:  2016-06-01       Impact factor: 3.623

View more
  3 in total

1.  One Health Approach to Zoonotic Parasites: Molecular Detection of Intestinal Protozoans in an Urban Population of Norway Rats, Rattus norvegicus, in Barcelona, Spain.

Authors:  María Teresa Galán-Puchades; María Trelis; Sandra Sáez-Durán; Susana Cifre; Carla Gosálvez; Joan Sanxis-Furió; Jordi Pascual; Rubén Bueno-Marí; Sandra Franco; Víctor Peracho; Tomás Montalvo; Màrius Vicent Fuentes
Journal:  Pathogens       Date:  2021-03-07

2.  Prevalence of Intestinal Parasitoses in a Non-Endemic Setting during a 10-Year Period (2011-2020): A Focus on Dientamoeba fragilis.

Authors:  Adriana Calderaro; Mirko Buttrini; Sara Montecchini; Sabina Rossi; Benedetta Farina; Maria Cristina Arcangeletti; Flora De Conto; Carlo Chezzi
Journal:  Microorganisms       Date:  2022-02-12

3.  Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.

Authors:  Ander Burgaña; Rosa Abellana; Stanislav Zlatanov Yordanov; Rabee Kazan; A Mauricio Pérez Ortiz; Cristina Castillo Ramos; Christian Garavito Hernández; Miriam Molina Rivero; Alessandra Queiroga Gonçalves; Emma Padilla; Josefa Pérez; Roger García-Puig; Tomas M Perez-Porcuna
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-11-11       Impact factor: 4.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.